We’re upgrading CrowdStrike despite a post-earnings stock drop
CrowdStrike shares declined Wednesday evening despite the cybersecurity firm reporting a clean beat across every key metric. While management raised
Read More
club earnings
We’re raising our price target on TJX after an impressive beat-and-raise quarter
TJX Companies on Wednesday reported better-than-expected quarterly results, vaulting over the high bar inherent for a stock hovering near its
Read More
Home Depot’s business momentum drives shares higher as investors jump in ahead of Fed rate
Home Depot shares soared Tuesday as investors saw past quarterly disappointments and looked forward to a better back half of
Read More
We’re upgrading our rating on Disney thanks to a misguided market reaction to earnings
Disney shares are under pressure Wednesday after the entertainment giant reported mixed quarterly results. We think it’s an opportunity. Revenue
Read More
We’re raising our Meta price target big time after a stellar quarter and an incredible guide
Meta Platforms shares soared Wednesday evening after the social media juggernaut delivered what can only be described as a blowout
Read More
Microsoft’s monster quarter and strong outlook cements its status as an AI leader
Microsoft shares surged in extended trading on Wednesday after the tech giant reported strong quarterly results, fueled by an acceleration
Read More
Is the post-earnings rally in this struggling life sciences stock for real this time?
The upward wave in shares of Danaher since the life sciences company reported second-quarter earnings has left patient investors wondering
Read More
Capital One shares climb as investors buy into the vision of its future with Discover
Capital One shares rose on Tuesday evening despite the company reporting an extremely noisy second-quarter result due to the Discover
Read More
Danaher’s imperfect quarter is good enough for us to stay the course
Danaher shares fluctuated between gains and losses Tuesday after the life science firm’s second-quarter earnings cleared Wall Street’s fairly low
Read More
Abbott stock fell victim to an old earnings season truth: It’s all about the guidance
Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed
Read More